The firm saw an increase in diagnostics solutions sales in the second quarter, particularly within its Quantiferon and QiaStat-Dx businesses.

Including its COVID-19-related business, the company's second quarter revenues were down 43 percent year over year.

At ADLM, the company provided a preview of its Liaison Nes point-of-care PCR instrument that is complementary to the firm's Liaison Plex syndromic testing system.